CeQur Develops Diabetes Compliance Device
An important drawback of current diabetes treatment regimens is patient compliance, particularly for insulin injections that are painful and must also be timely administered.
OneMedForum NY 2011
Accord Biosciences To Present At OneMedForum NY 2011
Nitric oxide is one of the most important physiological signaling molecules in the body, responsible for regulating such fundamental biological processes as proper blood vessel function and the body’s defense against infection.
MEDomics to Present At OneMedForum NY 2011
OneMedForum NY 2011 welcomes MEDomics, LLC, a molecular diagnostic laboratory, confirmed to present in June at the annual conference.
OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
ThermoGenesis to Begin Sale of Novel Stem Cell Device in India
ThermoGenesis said its device, used in processing stem cells from bone marrow, got Indian marketing approval, sending its shares up as much as 8 percent.
Is Europe A Better Place To Build A Medical Technology Company? (Video)
Growth in the life sciences industries will greatly depend on how the FDA responds to growing complaints that they are stifling medical technologies.
NeoStem to Present Stem Cell Technology at OneMedForum NY 2011
NeoStem , an international biopharmaceutical company, will present at OneMedForum NY 2011.
OneMedForum NY 2011 Advisory Board Steering Committee Assembled
OneMedForum is pleased to announce the assembly of the OneMedForum NY 2011 Steering Committee.
Accord Biosciences Receives $1.3M NIH SBIR Grant To Develop Pulmonary Hypertension Diagnostic
Last year, Accord Biosciences was awarded a Phase II National Institutes of Health Small Business Innovation Research grant of $1.3M to develop a point-of-care diagnostic for pulmonary arterial hypertension.